2010
DOI: 10.1038/aps.2010.118
|View full text |Cite
|
Sign up to set email alerts
|

Autophagic pathways as new targets for cancer drug development

Abstract: Autophagy is an evolutionarily conserved lysosomal self-digestion process involved in degradation of long-lived proteins and damaged organelles. In recent years, increasing evidence indicates that autophagy is associated with a number of pathological processes, including cancer. In this review, we focus on the recent studies of the evolutionarily conserved autophagy-related genes (ATGs) that are implicated in autophagosome formation and the pathways involved. We discuss several key autophagic mediators (eg, Be… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

3
72
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 99 publications
(78 citation statements)
references
References 120 publications
3
72
0
Order By: Relevance
“…12,13 This defines the Janus role of autophagy and its ability to control a wide range of physiological processes, such as starvation, cell differentiation, cell survival, and death. 14 Finally, necroptosis is characterized by the relatively smallest number of regulators. Typically, necroptosis is modulated by c-Jun N-terminal kinase (JNK), apoptosis inducing factor (AIF), death-associated protein kinase (DAPK), and reactive oxygen species, [15][16][17][18] whereas in the apoptosis-incompetent cells, necroptosis is activated by death receptors and involves the RIP1 kinase.…”
mentioning
confidence: 99%
“…12,13 This defines the Janus role of autophagy and its ability to control a wide range of physiological processes, such as starvation, cell differentiation, cell survival, and death. 14 Finally, necroptosis is characterized by the relatively smallest number of regulators. Typically, necroptosis is modulated by c-Jun N-terminal kinase (JNK), apoptosis inducing factor (AIF), death-associated protein kinase (DAPK), and reactive oxygen species, [15][16][17][18] whereas in the apoptosis-incompetent cells, necroptosis is activated by death receptors and involves the RIP1 kinase.…”
mentioning
confidence: 99%
“…ACD is marked with substantial mortification of cellular constituents, such as parts of the cytoplasm and intracellular organelles via intricate intracellular membrane/vesicle reformation and lysosomal hydrolysis [58][59][60]63]. Studies [58,59] have shown that ACD is essential for growth as well as stress antiphons.…”
Section: α-Mg and Autophagymentioning
confidence: 99%
“…Moreover, comparable to apoptosis, ACD is inhibited in malignant cancers. Studies have demonstrated that autophagy is triggered in reaction to γ irradiation and several anticancer remedies, specifically in apoptosis-deficient cells [58,63,64]. Numerous molecular and cell-signaling pathways have been incriminated in controlling autophagy.…”
Section: α-Mg and Autophagymentioning
confidence: 99%
“…Previous studies have identified high expression levels of eEF2K in several types of cancer, and suggested that eEF2K may promote cell proliferation during nutrient starvation in these tumors (19)(20)(21). eEF2K has been considered as a potential cancer-therapeutic target, and the use of miRNA delivery agents for the treatment of different types of cancer has been investigated in previous clinical trials (1,(22)(23)(24)(25). Therefore, the identification of novel anticancer miRNAs capable of targeting eEF2K is of importance.…”
Section: Introductionmentioning
confidence: 99%